Terms: = Germ cell tumor AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
118 results:
1. Fused deep learning paradigm for the prediction of o6-methylguanine-DNA methyltransferase genotype in glioblastoma patients: A neuro-oncological investigation.
Saxena S; Jena B; Mohapatra B; Gupta N; Kalra M; Scartozzi M; Saba L; Suri JS
Comput Biol Med; 2023 Feb; 153():106492. PubMed ID: 36621191
[TBL] [Abstract] [Full Text] [Related]
2. Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas.
Wu Y; Li H; Tan L; Lai Y; Li Z
Hum Pathol; 2023 Jan; 131():87-97. PubMed ID: 36370822
[TBL] [Abstract] [Full Text] [Related]
3. Can tumor treating fields induce DNA damage and reduce cell motility in medulloblastoma cell lines?
Nitta RT; Luo EJ; Lim M; Li G
J Neurosurg Pediatr; 2022 Dec; 30(6):555-566. PubMed ID: 36208441
[TBL] [Abstract] [Full Text] [Related]
4. Radiogenomics to characterize the immune-related prognostic signature associated with biological functions in glioblastoma.
Liu D; Chen J; Ge H; Yan Z; Luo B; Hu X; Yang K; Liu Y; Liu H; Zhang W
Eur Radiol; 2023 Jan; 33(1):209-220. PubMed ID: 35881182
[TBL] [Abstract] [Full Text] [Related]
5. Phase II study of Disulfiram and Cisplatin in Refractory germ cell tumors. The GCT-SK-006 phase II trial.
Mego M; Svetlovska D; Angelis V D; Kalavska K; Lesko P; Makovník M; Obertova J; Orszaghova Z; Palacka P; Rečková M; Rejlekova K; Z SM; Mardiak J; Chovanec M
Invest New Drugs; 2022 Oct; 40(5):1080-1086. PubMed ID: 35763178
[TBL] [Abstract] [Full Text] [Related]
6. Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms.
Iwasaki K; Barroga E; Enomoto M; Tsurui K; Shimoda Y; Matsumoto M; Miyoshi K; Ota Y; Matsubayashi J; Nagakawa Y
World J Surg Oncol; 2022 May; 20(1):165. PubMed ID: 35610656
[TBL] [Abstract] [Full Text] [Related]
7. The 31-gene expression profile stratifies recurrence and metastasis risk in patients with cutaneous melanoma.
Jarell A; Skenderis B; Dillon LD; Dillon K; Martin B; Quick AP; Siegel JJ; Rackley BB; Cook RW
Future Oncol; 2021 Dec; 17(36):5023-5031. PubMed ID: 34587770
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic factors and clinical nomogram predicting survival in high-grade glioma.
Tunthanathip T; Ratanalert S; Sae-Heng S; Oearsakul T; Sakarunchai I; Kaewborisutsakul A; Chotsampancharoen T; Intusoma U; Kitkhuandee A; Vaniyapong T
J Cancer Res Ther; 2021; 17(4):1052-1058. PubMed ID: 34528563
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.
Zaremba A; Philip M; Hassel JC; Glutsch V; Fiocco Z; Loquai C; Rafei-Shamsabadi D; Gutzmer R; Utikal J; Haferkamp S; Reinhardt L; Kähler KC; Weishaupt C; Moreira A; Thoms KM; Wilhelm T; Pföhler C; Roesch A; Ugurel S; Zimmer L; Stadtler N; Sucker A; Kiecker F; Heinzerling L; Meier F; Meiss F; Schlaak M; Schilling B; Horn S; Schadendorf D; Livingstone E
Eur J Cancer; 2021 Jul; 152():139-154. PubMed ID: 34102453
[TBL] [Abstract] [Full Text] [Related]
10. Differential effect of vascularity between long- and short-term survivors with IDH1/2 wild-type glioblastoma.
Álvarez-Torres MDM; Fuster-García E; Reynés G; Juan-Albarracín J; Chelebian E; Oleaga L; Pineda J; Auger C; Rovira A; Emblem KE; Filice S; Mollà-Olmos E; García-Gómez JM
NMR Biomed; 2021 Apr; 34(4):e4462. PubMed ID: 33470039
[TBL] [Abstract] [Full Text] [Related]
11. Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial.
Cloughesy TF; Petrecca K; Walbert T; Butowski N; Salacz M; Perry J; Damek D; Bota D; Bettegowda C; Zhu JJ; Iwamoto F; Placantonakis D; Kim L; Elder B; Kaptain G; Cachia D; Moshel Y; Brem S; Piccioni D; Landolfi J; Chen CC; Gruber H; Rao AR; Hogan D; Accomando W; Ostertag D; Montellano TT; Kheoh T; Kabbinavar F; Vogelbaum MA
JAMA Oncol; 2020 Dec; 6(12):1939-1946. PubMed ID: 33119048
[TBL] [Abstract] [Full Text] [Related]
12. High Neutrophil Count as a Negative Prognostic Factor for Relapse in Patients with Thymic Epithelial tumor.
Okada S; Shimomura M; Tsunezuka H; Ishihara S; Ikebe S; Furuya T; Shimada J; Teramukai S; Inoue M
Ann Surg Oncol; 2020 Jul; 27(7):2438-2447. PubMed ID: 31993857
[TBL] [Abstract] [Full Text] [Related]
13. Topological tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology.
Failmezger H; Muralidhar S; Rullan A; de Andrea CE; Sahai E; Yuan Y
Cancer Res; 2020 Mar; 80(5):1199-1209. PubMed ID: 31874858
[TBL] [Abstract] [Full Text] [Related]
14. Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival.
Bakker SH; Jacobs WCH; Pondaag W; Gelderblom H; Nout RA; Dijkstra PDS; Peul WC; Vleggeert-Lankamp CLA
Eur Spine J; 2018 Dec; 27(12):3043-3058. PubMed ID: 30220042
[TBL] [Abstract] [Full Text] [Related]
15. Nuclear Factor I Represses the Notch Effector HEY1 in Glioblastoma.
Brun M; Jain S; Monckton EA; Godbout R
Neoplasia; 2018 Oct; 20(10):1023-1037. PubMed ID: 30195713
[TBL] [Abstract] [Full Text] [Related]
16. Overall survival time prediction for high-grade glioma patients based on large-scale brain functional networks.
Liu L; Zhang H; Wu J; Yu Z; Chen X; Rekik I; Wang Q; Lu J; Shen D
Brain Imaging Behav; 2019 Oct; 13(5):1333-1351. PubMed ID: 30155788
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study.
Wei X; Mao L; Chi Z; Sheng X; Cui C; Kong Y; Dai J; Wang X; Li S; Tang B; Lian B; Yan X; Bai X; Zhou L; Guo J; Si L
Oncol Res; 2019 Mar; 27(4):495-501. PubMed ID: 30075827
[TBL] [Abstract] [Full Text] [Related]
18. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
[TBL] [Abstract] [Full Text] [Related]
19. [Early postsurgical temozolomide treatment in newly diagnosed bad prognosis glioblastoma patients: Feasibility study].
Chaskis E; Luce S; Goldman S; Sadeghi N; Melot C; De Witte O; Devriendt D; Lefranc F
Bull Cancer; 2018; 105(7-8):664-670. PubMed ID: 29937336
[TBL] [Abstract] [Full Text] [Related]
20. Predicting survival times for neuroblastoma patients using RNA-seq expression profiles.
Grimes T; Walker AR; Datta S; Datta S
Biol Direct; 2018 May; 13(1):11. PubMed ID: 29848365
[TBL] [Abstract] [Full Text] [Related]
[Next]
